Anderson, Dr. Gaylord, director, School of Public Health, University of Minnesota.. 611 Elwood, Dr. Paul, director, inpatient service, Sister Elizabeth Kenny 638 Jungeblut, Dr. Claus, professor of bacteriology, Columbia University-Kline, Marvin L., executive director, Sister Elizabeth Kenny Foundation__. 634 608 Additional information submitted for the record by- Diagnosis and treatment of infantile paralysis, by Edgar J. 651 The Kenny therapist... 655 Wolverton, Hon. Charles A.: Statistics on grants and appropriations, excerpt from hearings, Anderson, Dr. Gaylord, director, School of Public Health, University of Minnesota__ 702 Aufranc, Dr. W. H., Director, Health Resources Staff, Office of Defense Mobilization....... 715 Haas, Dr. Victor, Director, Microbiological Institute, Public Health Grant, Dr. David N. W., director, American National Red Cross blood program_ 712 752 Langmuir, Dr. Alexander, Communicable Disease Center, Atlanta, 756 Norton, Dr. Roy, State health department, Raleigh, N. C. Paffenbarger, Dr. Ralph S., Division of Civilian Health Requirements, Office of the Surgeon General, Public Health Service. Stokes, Dr. Joseph, physician in chief, Children's Hospital, Philadelphia, Pa... 727 721 695 Additional information submitted for the record by- Gamma globulin in the prophylaxis of poliomyelitis, prepared by 724 National program for the evaluation of gamma globulin, by 759 New York State Department of Health, statement of Dr. Robert F. 662 North Carolina State Board of Health: Organization and operation of mass inoculation clinics for the ad- 735 728 World Health Organization, poliomyelitis recognized as a worldwide danger, news release, September 22, 1953.. 701 POLIOMYELITIS (GENERAL) Agenda... Statement of Andrews, Dr. Justin M., Associate Chief, Bureau of State Services, Haas, Dr. Victor H., Director, National Microbiological Institute, Page 764 764 780 837 Hammon, Dr. W. McD., head, department of epidemiology and microbiology, University of Pittsburgh.. 809, 850, 853 Paul, Dr. John R., Yale University School of Medicine, New Haven, 808, 822, 852 Sabin, Dr. Albert, Children's Hospital Research Foundation, Cin- Switzer, Mary E., Director, Office of Vocational Rehabilitation.. Wise, Dr. Charles, professor of physical medicine and rehabilitation, 767 813 769, 848 855 Persons disabled by poliomyelitis rehabilitated in fiscal year 817 Poliomyelitis, prepared by National Microbiological Institute, Poliomyelitis distribution in the United States, by Dr. Robert E. 780 786 HEALTH INQUIRY (Poliomyelitis) TUESDAY, OCTOBER 6, 1953 HOUSE OF REPRESENTATIVES, COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE, Washington, D. C. The committee met, pursuant to adjournment, at 10 a. m. in the committee room of the House Committee on Interstate and Foreign Commerce, the Honorable Charles A. Wolverton (chairman) presiding. The CHAIRMAN. The committee will come to order. The schedule for these hearings seeking to bring before the American people certain important facts about health and disease called for this day, Tuesday, October 6, to be devoted to a discussion of the broad field of poliomyelitis, its importance as a disease, its cost in both human and economic terms, its unresolved medical problems, and its promising research areas. The National Foundation for Infantile Paralysis-a voluntary health agency in this field-is unable to be present here today because of prior involvement in a meeting now being held in West Virginia. The appearance of its representatives will be deferred until Monday, October 12, at which time we will expect also to hear authorities from the United States Public Health Service and other interested and informed scientists and laymen. The two aspects of polio prevention and treatment to be delved into today are suitable for separate hearings. This morning we will hear testimony from several witnesses on behalf of the Sister Kenny Foundation. This afternoon, beginning at 1:30 p. m., if the Sister Kenny witnesses have finished by that time, we will seek to get current information on the use of gamma globulin in connection with the prevention of poliomyelitis. We regret that Dr. Edwin J. Cohn, whose chemical research gave the world the polio combatant gamma globulin, died of a cerebral hemorrhage on Friday night last. A world leader in the basic research in the physical chemistry of proteins, Dr. Cohn's work made possible the fractionation of blood plasma during World War II. It provided serum albumin for the treatment of shock, glamma globulin for measles and polio, thrombin and fibrinogen which produce clotting for surgery, and other medically important blood fractions. His work resulted in the saving of thousands of lives by effective treatment of battlefield and accident shock and the alleviation of pernicious anemia through liver extract. Andrews, Dr. Justin M., Associate Chief, Bureau of State Services, 780 Haas, Dr. Victor H., Director, National Microbiological Institute, 837 Hammon, Dr. W. McD., head, department of epidemiology and microbiology, University of Pittsburgh.. 809, 850, 853 Paul, Dr. John R., Yale Üniversity School of Medicine, New Haven, 808, 822, 852 Sabin, Dr. Albert, Children's Hospital Research Foundation, Cin- Switzer, Mary E., Director, Office of Vocational Rehabilitation... 767 813 769, 848 Wise, Dr. Charles, professor of physical medicine and rehabilitation, Poliomyelitis, prepared by National Microbiological Institute, Poliomyelitis distribution in the United States, by Dr. Robert E. 855 817 780 786 HEALTH INQUIRY (Poliomyelitis) TUESDAY, OCTOBER 6, 1953 HOUSE OF REPRESENTATIVES, COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE, Washington, D. C. The committee met, pursuant to adjournment, at 10 a. m. in the committee room of the House Committee on Interstate and Foreign Commerce, the Honorable Charles A. Wolverton (chairman) presiding. The CHAIRMAN. The committee will come to order. The schedule for these hearings seeking to bring before the American people certain important facts about health and disease called for this day, Tuesday, October 6, to be devoted to a discussion of the broad field of poliomyelitis, its importance as a disease, its cost in both human and economic terms, its unresolved medical problems, and its promising research areas. The National Foundation for Infantile Paralysis-a voluntary health agency in this field-is unable to be present here today because of prior involvement in a meeting now being held in West Virginia. The appearance of its representatives will be deferred until Monday, October 12, at which time we will expect also to hear authorities from the United States Public Health Service and other interested and informed scientists and laymen. The two aspects of polio prevention and treatment to be delved into today are suitable for separate hearings. This morning we will hear testimony from several witnesses on behalf of the Sister Kenny Foundation. This afternoon, beginning at 1:30 p. m., if the Sister Kenny witnesses have finished by that time, we will seek to get current information on the use of gamma globulin in connection with the prevention of poliomyelitis. We regret that Dr. Edwin J. Cohn, whose chemical research gave the world the polio combatant gamma globulin, died of a cerebral hemorrhage on Friday night last. A world leader in the basic research in the physical chemistry of proteins, Dr. Cohn's work made possible the fractionation of blood plasma during World War II. It provided serum albumin for the treatment of shock, glamma globulin for measles and polio, thrombin and fibrinogen which produce clotting for surgery, and other medically important blood fractions. His work resulted in the saving of thousands of lives by effective treatment of battlefield and accident shock and the alleviation of pernicious anemia through liver extract. |